Nishan Sengupta

Nishan Sengupta has extensive work experience in the pharmaceutical industry. Nishan started their career at Abbott Laboratories in 2001 as an Assistant Director and Global Health Economics Team Leader for Immunology. Nishan then joined Roche Pharmaceuticals in 2004 as a Director of Medical Outcomes in Oncology and Supportive Care. In 2005, they moved to JNJ and held roles as the Director of Health Outcomes and Clinical Registry at Scios/JNJ and as the Director of Worldwide Health Economics and Pricing for Cardiovascular. In 2010, they joined Johnson & Johnson as the Market Access Leader for Xarelto and the CV Worldwide Market Access. Nishan later took on the role of Global Market Access Leader in Oncology/Hematology and, most recently, served as the Global/US Access Strategy Lead for IMBRUVICA, B-Cell, and Rare Hem. In 2021, Nishan Sengupta joined Geron Corporation as the Vice President of Market Access, Pricing, and Evidence Strategy.

Nishan Sengupta completed a PhD in economics at the University of Southern California from 1996 to 2000. In 2015, Nishan attended the Harvard Business School, but no specific degree or field of study is mentioned. Nishan also has a B Pharmacy/RPh degree in Pharmacy from Jadavpur University, although the start and end years are not provided.